Innoviva Inc. (INVA)
NASDAQ · Healthcare
Innoviva Inc. Revenue 2009–2025
Innoviva Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Innoviva Inc. revenue for the quarter ending March 31, 2026 was 98.0 M, a 10.56% increase year-over-year.
- Innoviva Inc. revenue for the twelve months ending March 31, 2026 was 394.7 M, a 18.12% increase year-over-year.
- Innoviva Inc. annual revenue for 2025 was 411.3 M, a 14.67% increase from 2024.
- Innoviva Inc. annual revenue for 2024 was 358.7 M, a 15.54% increase from 2023.
- Innoviva Inc. annual revenue for 2023 was 310.5 M, a 6.30% decrease from 2022.
- Innoviva Inc. annual revenue for 2022 was 331.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Innoviva Inc. (INVA) — Frequently Asked Questions
Innoviva Inc. (INVA) is a publicly traded US company. It has a market capitalization of $1.95B. In fiscal 2025 it reported revenue of $411M. Explore INVA's stock price, financial statements, earnings history, margins and key ratios below.
What is Innoviva Inc.'s market cap?
Innoviva Inc. (INVA) has a market capitalization of $1.95B.
What is the INVA stock price?
INVA trades at $23.00 (+2.04% on the day).
How much revenue does Innoviva Inc. make?
Innoviva Inc. reported revenue of $411M in fiscal 2025.